Plaquenil and Opdivo drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Plaquenil and Opdivo. Common interactions include hepatitis cholestatic among females and rash pruritic among males.
The phase IV clinical study analyzes what interactions people who take Plaquenil and Opdivo have. It is created by eHealthMe based on reports of 16 people who take Plaquenil and Opdivo from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
16 people who take Plaquenil and Opdivo together, and have interactions are studied.
What is Plaquenil?
Plaquenil has active ingredients of hydroxychloroquine sulfate. It is often used in systemic lupus erythematosus. eHealthMe is studying from 76,430 Plaquenil users for its effectiveness, alternative drugs and more.
What is Opdivo?
Opdivo has active ingredients of nivolumab. eHealthMe is studying from 35,355 Opdivo users for its effectiveness, alternative drugs and more.
Number of Plaquenil and Opdivo reports submitted per year:
Common Plaquenil and Opdivo drug interactions by gender *:
- Hepatitis cholestatic
- Lichenoid keratosis
- Rash pruritic
Common Plaquenil and Opdivo drug interactions by age *:
- Hepatitis cholestatic
- Lichenoid keratosis
Common conditions people have *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 43.75%
- Bronchial Carcinoma (lung cancer): 7 people, 43.75%
- Malignant Melanoma (skin cancer rises from melancytes): 2 people, 12.50%
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 12.50%
- Gout (uric acid crystals building up in the body): 2 people, 12.50%
- Muscle Spasms (muscle contraction): 1 person, 6.25%
- Lung Neoplasm (tumour of lung): 1 person, 6.25%
- Lung Cancer - Non-Small Cell (lung cancer): 1 person, 6.25%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.25%
- General Anaesthesia: 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Plaquenil and Opdivo?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Plaquenil and Opdivo:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Plaquenil interactions:
Browse all interactions between Plaquenil and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Opdivo interactions:
Browse all interactions between Opdivo and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on hydroxychloroquine sulfate and nivolumab (the active ingredients of Plaquenil and Opdivo, respectively), and Plaquenil and Opdivo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nail Abnormalities and Rash Erythematous Aggravated - now
- Vioxx and Methicillin-Resistant Staphylococcal Aureus Test Positive - 2 seconds ago
- Adalat Cc and Hepatic Failure - 5 seconds ago
- Fludarabine Phosphate and Posterior Reversible Encephalopathy Syndrome - 28 seconds ago
- Valtrex and Altered State Of Consciousness - 39 seconds ago